CAR T-Cell Symposium 2019

Chicago, IL US
September 27, 2019
Chimeric antigen receptor CAR T-cell ("Living Drug") immunotherapy is showing promising results in the treatment of cancers. University of Chicago faculty, along with national and international experts, will discuss the clinical and translational aspects of cell therapies both for hematologic malignancies and solid tumors.
 
This collaborative conference aims to make safe and cost-effective therapies a reality for patients globally in a cancer-free world.
 
Learn more by visiting www.chicagocartcell.com

Target Audience

This activity is designed for medical oncologists and oncology fellows, basic scientists, research fellows, nurses, clinical trial research staff, immunologists, surgeons, and other healthcare professionals interested in tumor immunology and immunotherapy.

Learning Objectives

At the conclusion of this activity, the learner will be able to:

  • Identify the current indications for CAR T-cell therapy in cancer, including acute lymphoblastic leukemia and aggressive large B-cell lymphoma;
  • Understand the grading and management of CAR T-cell related toxicities including cytokinerelease syndrome and neurologic toxicity;
  • Identify novel targets and future directions in cellular therapy;
  • Describe current approaches in nursing and supportive care for patients undergoing CAR T-cell therapy;
  • Discuss how the uses of CAR T-cell therapy differ in pediatric and young adult patients.
Additional information
ACGME/ABMS Core Competencies: 
Medical Knowledge
Interpersonal and Communication Skills
For more information, please contact:
CME Coordinator Contact Name: 
Meeting Achievements
CME Coordinator Contact Email: 
[email protected]
CME Coordinator Contact Phone: 
219-465-1115
Summary
Event starts: 
09/27/2019 - 8:00am
Event ends: 
09/27/2019 - 4:30pm
Activity opens: 
09/27/2019
Activity expires: 
12/27/2019
Part of: 
CAR T-Cell Symposium 2019
Add to calendar: 
The Gwen Hotel
521 N Rush St
Chicago, IL 60611
United States
American Board of Internal Medicine MOC II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
 
Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABIM. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees..

CLAIMING CREDIT: Click the button below.
Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABIM. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.

Please login or create an account to proceed.